In a May 12 Q&A, Dr. Gordon said the shutdown of elective care and research laboratories made it impossible for most informal interactions between colleagues (where innovative ideas are often born) to occur. She also said it prevented clinical studies from happening, which are often required to develop and test innovative products and treatments.
She said surgical innovation is delayed by a lack of funding. With hospitals still recovering from the elective surgery revenue they lost, they don’t have money for innovation investments or new products. With fewer innovations funded, the pipeline gets smaller.
To overcome these delays, Dr. Gordon recommended more community engagement across the research process, more inclusive clinical research participation and dissemination of innovative products in a culturally competent way.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
